Innate immune signaling in alcoholic liver disease
酒精性肝病中的先天免疫信号
基本信息
- 批准号:10022027
- 负责人:
- 金额:$ 24.06万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-23 至 2022-01-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAcute Alcoholic HepatitisAlcoholic HepatitisAlcoholic Liver DiseasesAlcoholsApoptosisAttenuatedBH3 DomainBiologicalBone MarrowCellsCharacteristicsChronicClinicalCyclic GMPDNADataDiseaseEndoplasmic ReticulumEventFutureGene ActivationHepatocyteHumanIRF3 geneImmuneImmune signalingIn VitroInflammasomeInflammationInterferonsInterventionKnowledgeLeaky GutLigandsLiverMediatingMitochondriaMitochondrial DNAMononuclearMusPathologyPathway interactionsPatientsPharmacologyPhosphorylationPlayPreclinical TestingProductionReportingResearchRoleSeveritiesSeverity of illnessSignal PathwaySignal TransductionSignaling MoleculeSmall Interfering RNASpecificitySterilityStimulator of Interferon GenesTLR4 geneTestingTherapeuticadenylate kinasealcohol effectbasecell injurychronic alcohol ingestionchronic liver diseasedesignds-DNAeffective therapyendoplasmic reticulum stressexperimental studygene therapyin vivoliver injurymacrophagemonocytemouse modelnew therapeutic targetnovelnovel therapeuticspre-clinicalpromotersensortherapeutic evaluation
项目摘要
Abstract
Alcoholic liver disease (ALD) and its clinically most devastating presentation, alcoholic hepatitis, is a result of
cumulative biological events such as leaky gut, hepatocyte damage and inflammation that collectively
contribute to the severity of liver damage. Our studies delineated a unique role for interferon regulatory factor 3
(IRF3) in alcohol-related inflammation and hepatocyte damage. We reported that the endoplasmic reticulum
(ER) adapter, stimulator of interferon genes (STING), is required for IRF3 phosphorylation and that IRF3
induces mitochondrial apoptosis in hepatocytes. Preliminary data shows that both alcohol binge or chronic
alcohol increase circulating bacterial 16S DNA and mitochondrial DNA levels in mice and humans. These
double stranded DNAs are ligands for the cyclic GMP-AMP kinase (cGAS) that produces 2′3′-cGAMP
(cGAMP) that can activate STING to trigger IRF3 activation and Type I IFN production. We postulate that
STING activation is at the crossroads of alcohol-induced liver pathology and in addition to ER stress, STING is
also activated via cGAS-cGAMP in ALD. We further hypothesize that cGAS-mediated signals and STING
activation represent a trigger for an acute-on-chronic alcohol-induced liver injury often seen in acute alcoholic
hepatitis. We proposee that the cGAS-cGAMP-STING activation axis plays a role both in hepatocytes and
immune cells in alcoholic hepatitis. We also discovered that sterile danger signals released by damaged
hepatocytes activate the NLRP3 inflammasome in immune cells and that disruption of inflammasome
activation pathways can ameliorate ALD in mice. We propose that inflammasome activation and ER stress are
bi-directionally regulated in ALD. Our Aims are: 1. To investigate the role of the DNA sensor, cGAS, and
dsDNA in STING-IRF3 activation in ALD; 2. To delineate the cell-specificity of cGAS and STING activation in
ALD in hepatocytes and innate immune cells; 3. To investigate interactions between ER stress, inflammasome
activation and STING-IRF3 activation in ALD; 4. To investigate the biological effect and therapeutic benefit of
cGAS and STING inhibition on liver damage, steatosis and inflammation in ALD. These experiments will test
novel roles of the cGAS-STING innate immune signaling pathways in ALD and identify key signaling
molecules, for designing new therapies for ALD.
摘要
酒精性肝病(ALD)及其临床上最具破坏性的表现,酒精性肝炎,是由于
累积的生物学事件,如肠漏、肝细胞损伤和炎症,
导致肝损伤的严重程度我们的研究描绘了干扰素调节因子3的独特作用
(IRF 3)在酒精相关炎症和肝细胞损伤中的作用。我们报道过内质网
(ER)衔接子,干扰素基因刺激因子(STING),是IRF 3磷酸化所必需的,IRF 3
诱导肝细胞线粒体凋亡。初步数据显示,酗酒或慢性
酒精增加循环细菌16 S DNA和线粒体DNA水平在小鼠和人类。这些
双链DNA是产生2′3′-cGAMP的环GMP-AMP激酶(cGAS)的配体
(cGAMP)可以激活STING以触发IRF 3激活和I型IFN产生。我们推测
STING激活处于酒精诱导的肝脏病理学的十字路口,并且除了ER应激之外,STING还
在ALD中也通过cGAS-cGAMP激活。我们进一步假设cGAS介导的信号和STING
激活代表了急性慢性酒精性肝损伤的触发因素,
肝炎我们认为cGAS-cGAMP-STING激活轴在肝细胞和肝细胞中起作用,
酒精性肝炎中的免疫细胞我们还发现,受损的植物释放的无菌危险信号
肝细胞激活免疫细胞中NLRP 3炎性体,
激活途径可以改善小鼠的ALD。我们认为炎性小体激活和内质网应激是
在ALD中双向调节。我们的目标是:1。为了研究DNA传感器cGAS的作用,
ALD中STING-IRF 3激活中的dsDNA; 2.为了描述cGAS和STING激活的细胞特异性,
肝细胞和先天免疫细胞中的ALD; 3.研究内质网应激、炎性小体、
ALD中的STING-IRF 3激活和STING-IRF 3激活; 4.目的:探讨生物学效应和治疗效果,
cGAS和STING抑制ALD中的肝损伤、脂肪变性和炎症。这些实验将测试
cGAS-STING先天免疫信号通路在ALD中的新作用,并确定关键信号通路
分子,用于设计ALD的新疗法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
                item.title }}
{{ item.translation_title }}
- DOI:{{ item.doi }} 
- 发表时间:{{ item.publish_year }} 
- 期刊:
- 影响因子:{{ item.factor }}
- 作者:{{ item.authors }} 
- 通讯作者:{{ item.author }} 
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:{{ item.author }} 
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:{{ item.author }} 
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:{{ item.author }} 
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:{{ item.author }} 
数据更新时间:{{ patent.updateTime }}
Gyongyi Szabo其他文献
Gyongyi Szabo的其他文献
{{
              item.title }}
{{ item.translation_title }}
- DOI:{{ item.doi }} 
- 发表时间:{{ item.publish_year }} 
- 期刊:
- 影响因子:{{ item.factor }}
- 作者:{{ item.authors }} 
- 通讯作者:{{ item.author }} 
{{ truncateString('Gyongyi Szabo', 18)}}的其他基金
Biomarkers of Disease in Alcoholic Hepatitis Administrative Supplement
酒精性肝炎行政补充剂中疾病的生物标志物
- 批准号:10840220 
- 财政年份:2023
- 资助金额:$ 24.06万 
- 项目类别:
Extracellular Vesicles in Alcoholic Liver Disease: Basic and Pre-Clinical Discovery
酒精性肝病中的细胞外囊泡:基础和临床前发现
- 批准号:10440307 
- 财政年份:2020
- 资助金额:$ 24.06万 
- 项目类别:
Extracellular Vesicles in Alcoholic Liver Disease: Basic and Pre-Clinical Discovery
酒精性肝病中的细胞外囊泡:基础和临床前发现
- 批准号:10167062 
- 财政年份:2020
- 资助金额:$ 24.06万 
- 项目类别:
Extracellular Vesicles in Alcoholic Liver Disease: Basic and Pre-Clinical Discovery
酒精性肝病中的细胞外囊泡:基础和临床前发现
- 批准号:10208640 
- 财政年份:2020
- 资助金额:$ 24.06万 
- 项目类别:
Alcoholic Hepatitis Clinical and Translational Network Late Phase Clinical Trials and Observational Studies 4/9
酒精性肝炎临床和转化网络后期临床试验和观察研究 4/9
- 批准号:10441258 
- 财政年份:2019
- 资助金额:$ 24.06万 
- 项目类别:
Alcoholic Hepatitis Clinical and Translational Network Late Phase Clinical Trials and Observational Studies 4/9
酒精性肝炎临床和转化网络后期临床试验和观察研究 4/9
- 批准号:10022622 
- 财政年份:2019
- 资助金额:$ 24.06万 
- 项目类别:
Extracellular Vesicles in Alcoholic Liver Disease: Basic and Pre-Clinical Discovery
酒精性肝病中的细胞外囊泡:基础和临床前发现
- 批准号:10022712 
- 财政年份:2019
- 资助金额:$ 24.06万 
- 项目类别:
Innate immune signaling in alcoholic liver disease
酒精性肝病中的先天免疫信号
- 批准号:10092047 
- 财政年份:2019
- 资助金额:$ 24.06万 
- 项目类别:
相似海外基金
A hepatocyte-specific R-spondin mimetic bispecific fusion protein to stimulate hepatocyte regeneration in patients with acute alcoholic hepatitis
一种肝细胞特异性 R-spondin 模拟双特异性融合蛋白,可刺激急性酒精性肝炎患者的肝细胞再生
- 批准号:10269934 
- 财政年份:2020
- 资助金额:$ 24.06万 
- 项目类别:
A hepatocyte-specific R-spondin mimetic bispecific fusion protein to stimulate hepatocyte regeneration in patients with acute alcoholic hepatitis
一种肝细胞特异性 R-spondin 模拟双特异性融合蛋白,可刺激急性酒精性肝炎患者的肝细胞再生
- 批准号:10488068 
- 财政年份:2020
- 资助金额:$ 24.06万 
- 项目类别:
A hepatocyte-specific R-spondin mimetic bispecific fusion protein to stimulate hepatocyte regeneration in patients with acute alcoholic hepatitis
一种肝细胞特异性 R-spondin 模拟双特异性融合蛋白,可刺激急性酒精性肝炎患者的肝细胞再生
- 批准号:10707988 
- 财政年份:2020
- 资助金额:$ 24.06万 
- 项目类别:
THALIDOMIDE IN PATIENTS WITH ACUTE ALCOHOLIC HEPATITIS
沙利度胺用于急性酒精性肝炎患者
- 批准号:7201331 
- 财政年份:2005
- 资助金额:$ 24.06万 
- 项目类别:
THALIDOMIDE IN PATIENTS WITH ACUTE ALCOHOLIC HEPATITIS
沙利度胺用于急性酒精性肝炎患者
- 批准号:7040813 
- 财政年份:2004
- 资助金额:$ 24.06万 
- 项目类别:
STUDIES OF AMINO ACID INFUSION IN ACUTE ALCOHOLIC HEPATITIS
氨基酸输注治疗急性酒精性肝炎的研究
- 批准号:4697975 
- 财政年份:
- 资助金额:$ 24.06万 
- 项目类别:

 刷新
              刷新
            
















 {{item.name}}会员
              {{item.name}}会员
            



